Find out how to buy and cost CRUSIA 60MG/0.6ML 2 SYR in Europe you can make a request on the site.
We will help in the preparation of customs documents and accompanying documentation for delivery CRUSIA 60MG/0.6ML 2 SYR , get permission from airport security.
Foreign citizens who purchase drugs while in Israel can receive a refund of VAT (TAX FREE) upon departure at the airport
Manufacturer: Tzamal BIO-Pharma
Amount in a package: 2
Manufacturer’s website link
Description: CRUSIA 60MG/0.6ML 2 SYR is a medication that belongs to the category of factor Xa inhibitors. It is used for the prevention and treatment of thromboembolic disorders, such as venous thromboembolism and arterial thrombosis. The medication contains the active ingredient rivaroxaban, which is a selective inhibitor of factor Xa, an important component in the blood clotting process. Rivaroxaban prevents the formation of blood clots by blocking factor Xa, reducing the risk of thromboembolic complications. The medication is available in the form of injection syringes, providing convenience and accurate dosing. It should only be used as prescribed by a doctor and under their supervision, as it may cause side effects such as bleeding. CRUSIA 60MG/0.6ML 2 SYR is an effective and safe treatment for the prevention and treatment of thromboembolic disorders in patients with various conditions.
CRUSIA is a brand that offers high-quality and stylish products for all your needs. And what better way to purchase them than through the convenience of the internet? By shopping online, you have access to a wide range of CRUSIA products at your fingertips, without having to leave the comfort of your own home. Not only that, but you can also compare prices and read reviews from other customers, ensuring that you are making the best purchase possible. With fast and reliable shipping, buying CRUSIA products online is the most convenient and efficient way to upgrade your lifestyle. So why wait? Start browsing and shopping on the CRUSIA website today!
Reviews
There are no reviews yet.